Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall pentaglycyl peptide bridging segment is a structural component found in the peptidoglycan layer of certain Gram-positive bacteria, notably *Staphylococcus aureus*. This segment, consisting of five glycine residues, connects peptide side chains attached to N-acetylmuramic acid (MurNAc) residues, providing strength and rigidity to the cell wall. It's a key target for antibiotics like lysostaphin and beta-lactams, and variations contribute to antibiotic resistance.
Inhibition of cross-linking; cleavage of pentaglycine bonds.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Cell Wall Pentaglycyl Peptide Bridging Segment (Pentaglycyl Bridge).